0 CHECKOUT

ATF Bank 'B+' Rating On Watch Pos And UniCredito Affirmed At 'A+/A-1' With Stable Outlook Jun 07

  • ID: 1831405
  • June 2007
  • Standard & Poors

FEATURED COMPANIES

  • ATF Bank
  • Capitalia SpA
  • UniCredit Bank AG
  • UniCredit Bank Austria AG
  • UniCredit SpA
  • MORE

Abstract
MILAN (Standard & Poor's) June 22, 2007--Standard & Poor's Ratings Services said today that, following news of Italian bank UniCredito Italiano SpA's share purchase agreement to acquire a major shareholding in ATF Bank, Kazakhstan's fourth-largest bank by assets, it has placed its 'B+' long-term counterparty credit rating on ATF on CreditWatch with positive implications and affirmed the 'B' short-term counterparty credit rating. At the same time, Standard & Poor's affirmed its 'A+' long-term and 'A-1' short-term counterparty credit ratings on UniCredito and its subsidiary Bank Austria Creditanstalt AG (BA-CA); the outlook on both of these entities is stable. The acquisition will be carried out through UniCredito's subsidiary BA-CA and is subject to regulatory authorizations. "The positive CreditWatch implications on ATF...

Companies mentioned in this report are:
- UniCredit SpA
- UniCredit Bank Austria AG
- Capitalia SpA
- UniCredit Bank AG
- ATF Bank

Action: Affirmed
Action: On CreditWatch:Positive

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, READ MORE >

Note: Product cover images may vary from those shown

- UniCredit SpA
- UniCredit Bank Austria AG
- Capitalia SpA
- UniCredit Bank AG
- ATF Bank

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This Credit Rating Report will be emailed to you.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.